Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
Dive Brief: French pharmaceutical company Ipsen will work with privately held biotechnology company Skyhawk Therapeutics to make small molecule drugs that modify RNA. Through a collaboration announced Monday, Ipsen and Skyhawk plan to develop multiple RNA- …